“invivodata was able to deliver us the real-time data that we needed to develop an unbiased view into our patients’ pain experiences. This kind of data cannot be collected with paper diaries.”
Dr. Michael Gendreau
Chief Medical Officer, Cypress Bioscience
invivodata Named as Finalist in Pittsburgh Technology Council Tech 50 Awards
- August 29, 2006
invivodata Named as Finalist in Pittsburgh Technology Council Tech 50 Awards
PITTSBURGH — August 9, 2006 — invivodata™ inc., inc., the industry leader in electronic patient reported outcomes (ePRO) solutions for global clinical research, today announced that the Pittsburgh Technology Council has named the company a finalist in the Life Sciences category of its Tech 50 Awards. These awards are presented annually to the region’s highest-achieving, most innovative technology firms.
“Our judges were impressed with invivodata’s technological advances in the collection of patient-reported outcomes data and its contribution to growing and sustaining the Pittsburgh technology industry,” said Steven G. Zylstra, president and CEO, Pittsburgh Technology Council. “Life sciences are a vital part of our regional economy, and strong growth from companies like invivodata helps to ensure that the industry at large continues to view Pittsburgh as a technology leader.”
Pharmaceutical and biotechnology companies face a long series of regulatory hurdles as they strive to obtain Food and Drug Administration approval for their life-saving and life-enhancing products. Clinical trials, especially those including Patient Reported Outcomes (PRO) data, comprise a key component of that process, one that can be costly, time-consuming and unreliable, especially when trial sponsors rely on data collected with traditional, manual paper diaries.
invivodata combines behavioral science with handheld and Web technology to capture the highest-quality PRO data for clinical research. invivodata’s electronic diary (eDiary) solutions have helped more than 50 pharmaceutical and biotechnology industry clients to capture more reliable and accurate clinical trial data directly from patients, helping those clients to better understand the safety and effectiveness of new medical treatments they are developing.
“invivodata has a strong history of leading the eDiary industry, and we’re proud that the Pittsburgh Technology Council has recognized our achievements by naming us a Tech 50 Awards finalist,” said Doug Enfer, president and CEO of invivodata. “We’ve demonstrated solid growth over the past several years, having consistently posted double-digit growth in revenues and an 18 percent increase in employee hires since 2004. This success positions us well to sustain momentum and continue helping our clients conduct more effective research.”
Each year the Tech 50 event honors those technology companies that demonstrated the strongest growth and advancement in product or sales success, financial strength, corporate citizenship, job growth and retention, and innovative product or technology. All applicants are subjected to a final audit and scoring by the Pittsburgh office of PricewaterhouseCoopers. Winners will be announced Oct. 19 at the Tech 50 Awards ceremony at Carnegie Music Hall in Pittsburgh.
About invivodata inc.
invivodata combines behavioral science, information technology and clinical expertise to capture the highest-quality electronic Patient Reported Outcomes (ePRO) data in clinical research. The invivodata solution, which includes DiaryPRO for real-time PRO data collection and SitePRO for site-based PRO data collection, is based on patented compliance methods that include a proven patient management system that gives researchers and sponsors visibility into study progress and improves trial efficiencies. Strengthened by its regulatory and scientific expertise, invivodata is the industry-leading eDiary provider for delivering primary efficacy data for FDA approvals. Its solutions have been used in 150 clinical trials worldwide by more than 60,000 patients, collecting over 89 million patient-initiated entries for studies in over 65 disease states. invivodata’s scalable business model enables it to satisfy diverse client needs and meet the increasing global demand for its innovative solutions. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA.
